RxDoctor Payments Data

Elise Pilger

Nurse Practitioner · Boonville, MONPI 1902390180

Payments from drug & device makers

$4,367in general payments, 2019–2025

Across 115 payments — averaging $37.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Novo Nordisk$247
  • AbbVie$169
  • Convatec Inc.$164
  • Astellas Pharma US Inc$139
  • Johnson & Johnson$135
  • plus $795 from 23 others

What the payments were for

  • Speaking & faculty fees$1,24829%
  • Travel & lodging$81919%
  • Food & beverage$2,17050%
  • Education$1303%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,367 in reported general payments places this provider in the 90th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$45,248
Medicare patients
304
Services billed
903

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron106$67,901
MounjaroTirzepatide35$41,141
MyrbetriqMirabegron48$27,312
OzempicSemaglutide21$24,297
Solifenacin Succinate95$3,314
Methenamine Hippurate18$2,107
Cephalexin199$1,941
Estradiol43$1,889
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$1,696
Trimethoprim26$1,325
Tamsulosin Hcl104$1,118
Cefdinir60$670
Finasteride38$484
Fluconazole29$483
Atorvastatin Calcium46$439

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$16$67,901106 claims
Astellas Pharma US IncMyrbetriq$139$27,31248 claims
Novo NordiskOzempic$247$24,29721 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Boonville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →